newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November

Presentations at AHA to highlight Lexeo's cardiovascular gene therapy pipeline, including preclinical programs in desmoplakin and TNNI3 cardiomyopathies New LX2006 data to be presented at ICAR demonstrating cardiac